Table 3 Descriptive statistics of the study groups
Parameter | Group A | Group B | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
N | min–max | Q1 | Q3 | Median | N | min–max | Q1 | Q3 | Median | |
WBC (109/L) | 41 | 3.32–20.06 | 9.51 | 14.4 | 13.19 | 49 | 8.23–25.40 | 10.05 | 14.38 | 11.82 |
CRP (mg/L) | 41 | 0.4–39.5 | 2.3 | 5.5 | 3.7 | 49 | 0.2–77.3 | 2.7 | 11.8 | 5.8 |
Band (%) | 41 | 63.5–92.0 | 74.2 | 79.4 | 76.8 | 49 | 55.7–91.0 | 66.7 | 80.8 | 71.7 |
PCT (μg/L) | 40 | 0.02–0.08 | 0.03 | 0.07 | 0.05 | 43 | 0.03–10.10 | 0.03 | 0.06 | 0.05 |
sRAGE (pg/mL) | 41 | 128.7–1686.6 | 352.5 | 787.5 | 594.9 | 49 | 48.9–4872.0 | 297.2 | 775.3 | 612.9 |
esRAGE (pg/mL) | 41 | 230.0–915.2 | 406.7 | 533.8 | 490.2 | 49 | 281.1–958.8 | 483.0 | 610.1 | 541.1 |
sRANKL (pg/mL) | 41 | 2046.5–85,437.5 | 4374.4 | 9168.7 | 6425.0 | 49 | 1075.0–75,875.0 | 7250.0 | 29,381.2 | 11,362.5 |
OPG (pg/mL) | 41 | 157.2–2048.4 | 332.3 | 1449.6 | 531.7 | 49 | 234.2–14,520 | 411.8 | 867.1 | 581.4 |